Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells. | Eur J Cell Biol | 2022 | 35667339 | PubTator, text mining | PubMed |
Human induced pluripotent stem cells generated from Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome patients with a homozygous mutation in the PSMB8 gene (NIHTVBi016-A, NIHTVBi017-A, NIHTVBi018-A). | Stem Cell Res | 2022 | 35660921 | PubTator, text mining | PubMed |
| MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer. | Biomark Res | 2022 | 35659780 | PubTator, text mining | PubMed |
| Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development. | Front Neurosci | 2022 | 35651633 | PubTator, text mining | PubMed |
| Differential Etv2 threshold requirement for endothelial and erythropoietic development. | Cell Rep | 2022 | 35649376 | PubTator, text mining | PubMed |
| Circulating cell-free DNA for cancer early detection. | Innovation (Camb) | 2022 | 35647572 | PubTator, text mining | PubMed |
| DNMT1 Expression and DNA Methylation in Intraductal Papillary Neoplasms of the Bile Duct. | Anticancer Res | 2022 | 35641291 | PubTator, text mining | PubMed |
| [The role of molecular genetic factors in the development of cholangiocellular carcinoma]. | Arkh Patol | 2022 | 35639847 | PubTator, text mining | PubMed |
| The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential. | BMC Biol | 2022 | 35637482 | PubTator, text mining | PubMed |
| Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity. | Curr Res Toxicol | 2022 | 35633891 | PubTator, text mining | PubMed |
| Porcine Intestinal Organoids: Overview of the State of the Art. | Viruses | 2022 | 35632851 | PubTator, text mining | PubMed |
| Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with PKD1 Mutation. | J Pers Med | 2022 | 35629189 | PubTator, text mining | PubMed |
| Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? | Genes (Basel) | 2022 | 35627145 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer. | Cancers (Basel) | 2022 | 35626111 | PubTator, text mining | PubMed |
| Human-Origin iPSC-Based Recellularization of Decellularized Whole Rat Livers. | Bioengineering (Basel) | 2022 | 35621497 | PubTator, text mining | PubMed |
| Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study. | Front Immunol | 2022 | 35619695 | PubTator, text mining | PubMed |
Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway. | Stem Cell Res Ther | 2022 | 35619172 | PubTator, text mining | PubMed |
| An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants. | Eur Respir J | 2022 | 35618278 | Swiss-Prot, curated | PubMed |
| A human breast atlas integrating single-cell proteomics and transcriptomics. | Dev Cell | 2022 | 35617956 | PubTator, text mining | PubMed |
| A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer. | Front Oncol | 2022 | 35615155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=52